This inventor holds 1 USPTO granted patent. Top assignee: Stiefel Laboratories, Inc.. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Allen L Lawson: Innovator in Oral Dosage Forms
Introduction
Allen L Lawson is a notable inventor based in Greenville, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms for water-insoluble drugs. His innovative approach has the potential to enhance the efficacy of various medications.
Latest Patents
One of Lawson's key patents is titled "Oral dosage forms of water insoluble drugs and methods of making the same." This patent outlines a method for creating an oral dosage form of water-insoluble drugs such as Saquinavir, Cyclosporine, or Paclitaxel. The process involves several steps, including the preparation of a single-phase working solution, the formation of particles from a pharmaceutically acceptable core material, and the combination of these elements to produce active agent-coated particles. The final steps include drying these particles and forming them into an oral dosage form. This innovative method addresses the challenges associated with delivering water-insoluble drugs effectively.
Career Highlights
Lawson is currently associated with Stiefel Laboratories, Inc., where he continues to work on advancing pharmaceutical formulations. His expertise in drug delivery systems has positioned him as a valuable asset in the industry. With 1 patent to his name, Lawson's work exemplifies the intersection of science and innovation in healthcare.
Collaborations
Throughout his career, Lawson has collaborated with esteemed colleagues, including Ranga Raju Namburi and John Elgin Kerr. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Allen L Lawson's contributions to the field of oral dosage forms demonstrate his commitment to improving drug delivery systems. His innovative methods have the potential to significantly impact the effectiveness of water-insoluble medications.